Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : ProxyMed (PILL) -- Ignore unavailable to you. Want to Upgrade?

To: ubrx who wrote (223)	5/2/2000 4:14:00 PM
From: tuck	Respond to of 261

James, I'm guessing the latter. Tough to evaluate until the conversion terms are available. Company insists its business is OK. I sort of wish they'd held off announcing some of the news they've put out recently, which got wasted in the face of this double whammy. Though you can't hold off earnings reports. Now they'll have to spend dough saying it again and again. Note that they have not reached agreement with ~13% of the preferred holders. I say watch, and nibble if you're in a gambling mood and worried about missing a ground floor opportunity -- which even if you join at this stage could still mean the chance of being in the class in the class action suit that is almost sure to come. I say that only partly in jest. Cheers, Tuck

To: ubrx who wrote (223)	5/5/2000 10:33:00 AM
From: tuck	Read Replies (1) \| Respond to of 261

James, Here's the good news, such as it is. We already had our anticipatory bounce, so we're getting nothing out of it. Holders of the other $2 million have mostly converted, and PILL will issue cash and warrants to the converters. I suppose I'll dive into the filings and see what the terms of the warrants are, but it will probably be a few days before it pops up at the SEC. Dilution spiral continues. siliconinvestor.com Cheers, Tuck